- Home
- NAMS vs MEOH Comparison
NAMS vs MEOH Comparison
Compare NAMS & MEOH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAMS
- MEOH
- Stock Information
- Founded
- NAMS 2019
- MEOH 1968
- Country
- NAMS Netherlands
- MEOH Canada
- Employees
- NAMS N/A
- MEOH N/A
- Industry
- NAMS Biotechnology: Pharmaceutical Preparations
- MEOH Major Chemicals
- Sector
- NAMS Health Care
- MEOH Industrials
- Exchange
- NAMS Nasdaq
- MEOH Nasdaq
- Market Cap
- NAMS 2.7B
- MEOH 3.1B
- IPO Year
- NAMS N/A
- MEOH N/A
- Fundamental
- Price
- NAMS $18.57
- MEOH $44.25
- Analyst Decision
- NAMS Strong Buy
- MEOH Buy
- Analyst Count
- NAMS 7
- MEOH 7
- Target Price
- NAMS $41.33
- MEOH $62.57
- AVG Volume (30 Days)
- NAMS 646.5K
- MEOH 436.1K
- Earning Date
- NAMS 03-04-2025
- MEOH 01-29-2025
- Dividend Yield
- NAMS N/A
- MEOH 1.67%
- EPS Growth
- NAMS N/A
- MEOH N/A
- EPS
- NAMS N/A
- MEOH 2.39
- Revenue
- NAMS $33,594,000.00
- MEOH $3,719,829,000.00
- Revenue This Year
- NAMS $131.53
- MEOH $17.72
- Revenue Next Year
- NAMS N/A
- MEOH $6.30
- P/E Ratio
- NAMS N/A
- MEOH $18.23
- Revenue Growth
- NAMS 78.77
- MEOH N/A
- 52 Week Low
- NAMS $15.19
- MEOH $36.13
- 52 Week High
- NAMS $27.29
- MEOH $56.43
- Technical
- Relative Strength Index (RSI)
- NAMS 29.65
- MEOH 31.00
- Support Level
- NAMS $18.88
- MEOH $50.48
- Resistance Level
- NAMS $20.46
- MEOH $54.49
- Average True Range (ATR)
- NAMS 1.11
- MEOH 1.52
- MACD
- NAMS -0.09
- MEOH -0.73
- Stochastic Oscillator
- NAMS 5.84
- MEOH 0.39
About NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
About MEOH Methanex Corporation
Methanex Corp manufactures and sells methanol. Methanex's customers use methanol as a feedstock to produce end-products including adhesives, foams, solvents, and windshield washer fluids. The firm also sells its products to the oil refining industry, where the methanol is blended with gasoline to produce a high-octane fuel or blended as a component of biodiesel. Methanex distributes its products through a global supply chain that includes the operation of port terminals, tankers, barges, rail cars, trucks, and pipelines. China generates the most revenue of any geographical segment.